Dearterialization of colorectal liver cancer: Institutional experience

Digestive Surgery

Volumn 16, Issue 3, 1999, Pages 229-235

  Ohlsson, B ^b   Lindell, G ^b   Lundstedt, C ^b   Jeppsson, B ^b   Persson, B ^b   Bengmark, S ^b   Tranberg, K G ^a  

^a LUND UNIVERSITY   (Sweden)

^b NONE

Author keywords

Dearterialization; Ischaemic therapy; Liver neoplasm; Metastases, colorectal

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MITOMYCIN;

ABDOMINAL ABSCESS; ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CARCINOMA; DEVASCULARIZATION; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER ABSCESS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; TREATMENT OUTCOME; TUMOR VOLUME;

BALLOON DILATATION; CATHETERIZATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032777858     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018713     Document Type: Article

References (32)

1. Breedis C, Young G: The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-985.
2. Ackerman NB: The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974; 75:589-596.
3. Wang LQ, Persson BG, Bergqvist L, Bengmark S: Influence of dearterialization on distribution of absolute tumor blood flow between hepatic artery and portal vein. Cancer 1994;74:2454-2459.
4. Nilsson LA: Therapeutic hepatic artery ligation in patients with secondary liver tumors. Rev Surg 1966;23:374-376.
5. Almersjö O, Bengmark S, Engevik L, Hafström LO, Nilsson LA: Hepatic artery ligation as pretreatment for liver resection of metastatic cancer. Rev Surg 1966;23:377-380.
6. Mori W, Masuda M, Miyanaga T: Hepatic artery ligation and tumor necrosis in the liver. Surgery 1966;59:359-363.
7. Petrelli NJ, Barcewicz PA, Evans JT, Ledesma EJ, Lawrence DD, Mittelman A: Hepatic artery ligation for liver metastasis in colorectal carcinoma. Cancer 1984;53:1347-1353.
8. Bengmark S, Rosengren K: Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am J Surg 1970;119:620-624.
9. Balasegaram M: Complete hepatic dearterialization for primary carcinoma of the liver: Report of twenty-four patients. Am J Surg 1972; 124:340-345.
10. Bengmark S, Fredlund P, Hafström LO, Vang J: Present experiences with hepatic dearterialization in liver neoplasm. Prog Surg 1974;13: 141-166.
11. Bengmark S, Nobin A, Jeppsson B, Tranberg K-G: Transient repeated dearterialization combined with intra-arterial infusion of oncolytic drugs in the treatment of liver tumors. Recent Results Cancer Res 1983;86:68-74.
12. Lise M, Cagol PP, Nitti D, Cartei G, Petrin P, Pucciarelli S, Andriulo B, Da Pian PP: Repeated transient hepatic dearterialization followed by infusion and systemic chemotherapy in the treatment of diffuse hepatic tumours. Chemioter Oncol 1979;3:224-229.
13. Ekberg H, Tranberg K-G, Lundstedt C, Hanff G, Ranstam J, Jeppsson B, Bengmark S: Determinants of survival after intraarterial infusion of 5-fluorouracil for liver metastases from colorectal cancer: A multivariate analysis. J Surg Oncol 1986;31:246-254.
14. Persson BG, Jeppsson B, Andersson L, Strand SE, Ekelund E, Bengmark S: The prevention of arterial collaterals after repeated temporary blockade of the hepatic artery in pigs. World J Surg 1987;11:672-677.
15. Puntis MCA, Persson B, Jonsson G, Jeppsson B, Bengmark S: Free radical production in the ischemic rat liver. Surg Res Commun 1987;1: 17-22.
16. Bengmark S, Jeppsson B, Lunderquist A, Tranberg K-G, Persson B: Tumour calcification following repeated hepatic de-arterialization in patients: A preliminary communication. Br J Surg 1988;75:525-526.
17. Persson BG, Jeppsson B, Ekberg H, Tranberg K-G, Lundstedt C, Bengmark S: Repeated dearterialization of hepatic tumors with an implantable occluder. Cancer 1990;66:1139-1146.
18. Bengmark S, Fredlund PE: Temporary dearterialization combined with intra-arterial infusion of oncolytic drugs in the treatment of liver tumors. Prog Clin Cancer 1978;7:207-216.
19. Ohlssdn B, Tranberg K-G, Lundstedt C, Ekberg H, Hederström E: Detection of hepatic metastases in colorectal cancer: A prospective study of laboratory and imaging methods. Eur J Surg 1993;159:275-281.
20. Hayward JE, Carbone PP, Heusen JC, Kumaoka S, Segaloff A, Rubens RD: Assessment of response to therapy in advanced breast cancer. Br J Cancer 1977;35:292-298.
21. Wood CB, Gillis CR, Blumgart LH: A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-288.
22. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J: Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-1410.
23. Russell AH, Tong DT, Dawson LE, Wisbeck W: Adenocarcinoma of the proximal colon: Sites of initial dissemination and patterns of recurrence following surgery alone. Cancer 1984;53:360-367.
24. Willett CG, Tepper JE, Cohen AM, Orlow E, Welch CE: Failure patterns following curative resection of colonic carcinoma. Ann Surg 1984; 200:685-690.
25. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-258.
26. Nordic Gastrointestinal Tumor Adjuvant Therapy Group: Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial. J Clin Oncol 1992;10:904-911.
27. Nordic Gastrointestinal Tumour Adjuvant Therapy Group: Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: A randomized trial. J Clin Oncol 1989;7:1437-1446.
28. Lin G, Hägerstrand I, Lunderquist A: Portal blood supply of liver metastases. AJR 1984; 143:53-55.
29. Kan Z, Ivancev K, Lunderquist A, McCuskey PA, Wright KC, Wallace S, McCuskey RS: In vivo microscopy of hepatic tumors in animal models: A dynamic investigation of blood supply to hepatic metastases. Radiology 1993;187: 621-626.
30. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763.
31. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lac WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
32. Möller PH, Ivarsson K, Roos G, Radnell M, Persson B, Tranberg K-G, Stenram U: Angiogenesis inhibitor TNP-470 augments the effect of repeated arterial ischemia on growth but does not affect take in a rat liver tumor model. Anticancer Res 1997;17:2401-2406.